Developer docs
API playgroundTry for free, no card

Search company profiles

Activen Sa

Full company profile

uuid00spvdv

Namestring
Activen Sa
Legal namestring
Activen SA
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Activen SA is a privately held Swiss biotechnology company, founded in 2011 and headquartered in Lausanne, that develops and commercializes a novel class of dermo-cosmetic active ingredients based on miniproteins™—small proteins, typically derived from the genomic sequences of living organisms, that are small enough to penetrate the skin topically while retaining high specificity and efficacy on cellular targets such as fibroblasts, keratinocytes, nervous cells, immune cells, and melanocytes. The company's discovery platform is anchored by a proprietary database of more than 100,000 miniproteins, less than 1% of which have known functions, providing a deep pipeline of untapped actives across anti-aging, regenerative dermatology, neuro-dermatology, and immuno-dermatology. Two ingredients are currently commercialized: XEP®-018, a best-in-class topical muscle relaxant derived from the venom of the sea snail Conus consors that reduces fine lines and wrinkles in as little as two hours and is positioned as a non-invasive alternative to botulinum toxin; and XEP®-716, a first-in-class growth factor miniprotein targeting TGF-β pathways for multipotent skin rejuvenation.

Activen operates a B2B ingredient-supply business model, selling miniprotein actives either by chemical synthesis or bioproduction to cosmetic brands and to contract manufacturers (façonniers) that produce on behalf of major beauty houses; named end-customers include Chanel, L'Oréal, and Nivéa, reached indirectly through these manufacturers. Pricing is not publicly disclosed and is engaged via brochure requests and direct contact. The company is led by President Jean-Marc Le Doussal, who brought pharmaceutical-industry scientific rigor to the cosmetics sector, and Marketing Director Élodie Jean-Louis, with operational headcount of 1–10 employees. Research and development is conducted at a center in Nantes, France, while the commercial headquarters is in Lausanne, Switzerland; the company has received international industry awards in Switzerland, France, and the United States for laboratory innovation.

Short descriptiontext

Activen SA is a Swiss biotech that discovers and supplies miniprotein-based active ingredients—such as the muscle relaxant XEP-018 and growth factor XEP-716—to cosmetic brands and contract manufacturers serving the dermo-cosmetic industry.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLausanne, Switzerland
HQ citystring
Lausanne
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
dermo-cosmetic active ingredients, miniprotein cosmetic actives, anti-aging skincare ingredients, cosmetic biotechnology platform, skin regeneration actives
Industry2 codes
PRIMARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
SECONDARYCRABAAAB
Treatment Skincare (Serums, Actives, Acne & Anti-aging)
NAICS code1 code
  • Soap and Cleaning Compound Manufacturing32561
Product category
Dermo-cosmetic Active Ingredients
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Active Ingredient Sales
TypeLicensing Royalties
Description

Activen develops and commercializes miniprotein active ingredients to cosmetic brands and contract manufacturers (façonniers). The company produces and sells miniproteins that can be chemically synthesized or bioproduced according to high quality standards, delivering constant purity and full traceability through a simplified supply chain.

activen-cosmetics.ch
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1XEP-018 miniprotein
Description

Best-in-class muscle relaxant miniprotein derived from sea snail venom (Conus consors). Applied topically for non-invasive wrinkle reduction with visible results in 2 hours.

activen-cosmetics.ch
+1 more record
Core offering1 text field

Activen develops and commercializes proprietary miniprotein™ active ingredients for the dermo-cosmetic industry. The company scouts genomic sequences of living organisms to identify small proteins that can penetrate the skin and modulate specific cellular receptors, then supplies these miniprotein actives to cosmetic brands and contract manufacturers for incorporation into anti-aging, skin regeneration, neuro-dermatology, and immuno-dermatology formulations. Its two commercial products are XEP®-018 (a muscle relaxant miniprotein for wrinkle reduction) and XEP®-716 (a growth factor miniprotein for skin rejuvenation).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Visible reduction in fine lines and wrinkles within 2 hours of application (XEP-018)
+2 more records
Product overview1 text field

Activen Sa is a biotech company that has pioneered a new class of active ingredients called miniproteins™ for the dermo-cosmetic industry. The company scouts genomic sequences of living organisms to discover naturally occurring molecules that can penetrate the skin. Their product portfolio consists of two commercial miniprotein actives: XEP®-018 MINIPROTEIN™ (a best-in-class muscle relaxant for wrinkle reduction) and XEP®-716 MINIPROTEIN™ (a first-in-class growth factor for skin rejuvenation and regeneration). The company maintains a proprietary database of over 100,000 miniproteins and conducts R&D programs in anti-aging, regenerative dermatology, neuro-dermatology, and immuno-dermatology.

Product and service2 records
1XEP®-018 MINIPROTEIN™
CategoryDermo-cosmetic active ingredient
Description

Best-in-class muscle relaxant miniprotein derived from the venom of the sea snail Conus consors. Applied topically as a cosmetic active, it penetrates the skin to exert muscle relaxant activity, reducing fine lines and wrinkles in as fast as 2 hours and providing cumulative anti-aging effects after 1 month of use. Targeted at dermo-cosmetic brands and contract manufacturers formulating premium anti-aging skincare products.

2XEP®-716 MINIPROTEIN™
CategoryDermo-cosmetic active ingredient
Description

First-in-class growth factor miniprotein naturally occurring in some living organisms, discovered by Activen. Its 3D folded structure enables skin penetration that conventional growth factors cannot achieve, delivering multipotent rejuvenating action through daily cosmetic formulation application and targeting TGF-β pathways for skin renewal, tissue regeneration, and wound healing. Targeted at dermo-cosmetic brands and contract manufacturers developing regenerative and anti-aging skincare ranges.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Lipotec, now part of Lubrizol, is a biotechnology-based ingredient company specializing in peptide-based cosmetic actives, including the well-known Argireline muscle-relaxant peptide — a direct functional competitor to Activen's XEP-018.

TypeBroad incumbent
Description

Givaudan Active Beauty is a global leader in cosmetic ingredients and fragrance, offering biotech-derived actives, peptides, and natural extracts. It serves all major cosmetic brands with broader portfolio and deeper resources than Activen.

TypeBroad incumbent
Description

Evonik's Care Solutions business produces specialty cosmetic ingredients including peptides, ceramides, and biotech actives, serving the same brand customers as Activen but as part of a much larger specialty chemicals portfolio.

TypeDirect peer
Description

CLR Berlin develops and manufactures cosmetic active ingredients from natural and biotechnological sources for skin and hair care applications, serving the same dermo-cosmetic brand customer base as Activen.

5Mibelle Biochemistry
TypeDirect peer
Description

Swiss-based Mibelle Biochemistry develops high-tech bioactive cosmetic ingredients using biotechnology, plant cell culture, and peptides — closely matching Activen's positioning as a Swiss biotech ingredient supplier to premium cosmetic brands.

TypeEmerging player
Description

BIOEFFECT uses biotechnology to produce growth factor-based skincare, including EGF. Its topical growth factor technology overlaps with Activen's XEP-716 TGF-β-targeting miniprotein, although BIOEFFECT markets finished skincare rather than B2B ingredients.

TypeDirect peer
Description

Active Concepts develops innovative cosmetic active ingredients through biotechnology and biofermentation, with a similar B2B ingredient-supplier model targeting cosmetic brands and formulators.

TypeDirect peer
Description

Sederma, a Croda subsidiary, develops biotech-derived bioactive ingredients for cosmetics, including peptides and proteins targeting anti-aging and skin regeneration — directly comparable to Activen's miniprotein technology and target customers.

TypeBroad incumbent
Description

DSM Personal Care develops and markets bioactive cosmetic ingredients, including peptides and vitamins, for major beauty brands globally. It is a broad incumbent offering biotech actives alongside vitamins and UV filters.

10Lucas Meyer Cosmetics (IFF)
TypeDirect peer
Description

Lucas Meyer Cosmetics, part of IFF, develops and markets phospholipid- and peptide-based cosmetic actives. It competes in the same biotech-derived dermo-cosmetic ingredient category as Activen and supplies similar major brand customers.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Activen Sa

Dermo-cosmetic Active Ingredientsactiven-cosmetics.ch

Activen SA is a Swiss biotech that discovers and supplies miniprotein-based active ingredients—such as the muscle relaxant XEP-018 and growth factor XEP-716—to cosmetic brands and contract manufacturers serving the dermo-cosmetic industry.

What Activen Sa does

Activen SA is a privately held Swiss biotechnology company, founded in 2011 and headquartered in Lausanne, that develops and commercializes a novel class of dermo-cosmetic active ingredients based on miniproteins™—small proteins, typically derived from the genomic sequences of living organisms, that are small enough to penetrate the skin topically while retaining high specificity and efficacy on cellular targets such as fibroblasts, keratinocytes, nervous cells, immune cells, and melanocytes. The company's discovery platform is anchored by a proprietary database of more than 100,000 miniproteins, less than 1% of which have known functions, providing a deep pipeline of untapped actives across anti-aging, regenerative dermatology, neuro-dermatology, and immuno-dermatology. Two ingredients are currently commercialized: XEP®-018, a best-in-class topical muscle relaxant derived from the venom of the sea snail Conus consors that reduces fine lines and wrinkles in as little as two hours and is positioned as a non-invasive alternative to botulinum toxin; and XEP®-716, a first-in-class growth factor miniprotein targeting TGF-β pathways for multipotent skin rejuvenation.

Activen operates a B2B ingredient-supply business model, selling miniprotein actives either by chemical synthesis or bioproduction to cosmetic brands and to contract manufacturers (façonniers) that produce on behalf of major beauty houses; named end-customers include Chanel, L'Oréal, and Nivéa, reached indirectly through these manufacturers. Pricing is not publicly disclosed and is engaged via brochure requests and direct contact. The company is led by President Jean-Marc Le Doussal, who brought pharmaceutical-industry scientific rigor to the cosmetics sector, and Marketing Director Élodie Jean-Louis, with operational headcount of 1–10 employees. Research and development is conducted at a center in Nantes, France, while the commercial headquarters is in Lausanne, Switzerland; the company has received international industry awards in Switzerland, France, and the United States for laboratory innovation.

Activen Sa firmographics

Firmographics
Name
Activen Sa
Legal name
Activen SA
Website
https://activen-cosmetics.ch
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
1–10 employees
Short description
Activen SA is a Swiss biotech that discovers and supplies miniprotein-based active ingredients—such as the muscle relaxant XEP-018 and growth factor XEP-716—to cosmetic brands and contract manufacturers serving the dermo-cosmetic industry.
Ownership category
akta.pro rank

Activen Sa industry classification

Industry
Product category
Dermo-cosmetic Active Ingredients
NAICS
Soap and Cleaning Compound Manufacturing (32561)
akta.pro industry
PRIMARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
SECONDARYCRABAAAB
Treatment Skincare (Serums, Actives, Acne & Anti-aging)

Keywords

  • Dermo-cosmetic active ingredients
  • Miniprotein cosmetic actives
  • Anti-aging skincare ingredients
  • Cosmetic biotechnology platform
  • Skin regeneration actives

Where Activen Sa is headquartered

Location

Headquarters

HQ city
Lausanne
HQ country
Switzerland
HQ region
Europe

Offices2 records

Markets served

Activen Sa business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Active Ingredient Sales: Activen develops and commercializes miniprotein active ingredients to cosmetic brands and contract manufacturers (façonniers). The company produces and sells miniproteins that can be chemically synthesized or bioproduced according to high quality standards, delivering constant purity and full traceability through a simplified supply chain.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Activen Sa product offering

Product offering

Core offering

Activen develops and commercializes proprietary miniprotein™ active ingredients for the dermo-cosmetic industry. The company scouts genomic sequences of living organisms to identify small proteins that can penetrate the skin and modulate specific cellular receptors, then supplies these miniprotein actives to cosmetic brands and contract manufacturers for incorporation into anti-aging, skin regeneration, neuro-dermatology, and immuno-dermatology formulations. Its two commercial products are XEP®-018 (a muscle relaxant miniprotein for wrinkle reduction) and XEP®-716 (a growth factor miniprotein for skin rejuvenation).

Product overview

Activen Sa is a biotech company that has pioneered a new class of active ingredients called miniproteins™ for the dermo-cosmetic industry. The company scouts genomic sequences of living organisms to discover naturally occurring molecules that can penetrate the skin. Their product portfolio consists of two commercial miniprotein actives: XEP®-018 MINIPROTEIN™ (a best-in-class muscle relaxant for wrinkle reduction) and XEP®-716 MINIPROTEIN™ (a first-in-class growth factor for skin rejuvenation and regeneration). The company maintains a proprietary database of over 100,000 miniproteins and conducts R&D programs in anti-aging, regenerative dermatology, neuro-dermatology, and immuno-dermatology.

Differentiator

Problem solved

Functional benefit

Brands

  • XEP-018 miniprotein: Best-in-class muscle relaxant miniprotein derived from sea snail venom (Conus consors). Applied topically for non-invasive wrinkle reduction with visible results in 2 hours.
  • XEP-716 miniprotein

Products and services

  • XEP®-018 MINIPROTEIN™ Best-in-class muscle relaxant miniprotein derived from the venom of the sea snail Conus consors. Applied topically as a cosmetic active, it penetrates the skin to exert muscle relaxant activity, reducing fine lines and wrinkles in as fast as 2 hours and providing cumulative anti-aging effects after 1 month of use. Targeted at dermo-cosmetic brands and contract manufacturers formulating premium anti-aging skincare products.
  • XEP®-716 MINIPROTEIN™ First-in-class growth factor miniprotein naturally occurring in some living organisms, discovered by Activen. Its 3D folded structure enables skin penetration that conventional growth factors cannot achieve, delivering multipotent rejuvenating action through daily cosmetic formulation application and targeting TGF-β pathways for skin renewal, tissue regeneration, and wound healing. Targeted at dermo-cosmetic brands and contract manufacturers developing regenerative and anti-aging skincare ranges.

Quantifiable outcome

  • Visible reduction in fine lines and wrinkles within 2 hours of application (XEP-018)
  • +2 more outcomes

Companies that use Activen Sa

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles1 record

Activen Sa technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Activen Sa partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Activen Sa competitors and assessment

Company assessment

Direct peers

  • Lipotec (Lubrizol Life Science): Lipotec, now part of Lubrizol, is a biotechnology-based ingredient company specializing in peptide-based cosmetic actives, including the well-known Argireline muscle-relaxant peptide — a direct functional competitor to Activen's XEP-018.
  • CLR Berlin: CLR Berlin develops and manufactures cosmetic active ingredients from natural and biotechnological sources for skin and hair care applications, serving the same dermo-cosmetic brand customer base as Activen.
  • Mibelle Biochemistry: Swiss-based Mibelle Biochemistry develops high-tech bioactive cosmetic ingredients using biotechnology, plant cell culture, and peptides — closely matching Activen's positioning as a Swiss biotech ingredient supplier to premium cosmetic brands.
  • Active Concepts: Active Concepts develops innovative cosmetic active ingredients through biotechnology and biofermentation, with a similar B2B ingredient-supplier model targeting cosmetic brands and formulators.
  • Sederma (Croda International): Sederma, a Croda subsidiary, develops biotech-derived bioactive ingredients for cosmetics, including peptides and proteins targeting anti-aging and skin regeneration — directly comparable to Activen's miniprotein technology and target customers.
  • Lucas Meyer Cosmetics (IFF): Lucas Meyer Cosmetics, part of IFF, develops and markets phospholipid- and peptide-based cosmetic actives. It competes in the same biotech-derived dermo-cosmetic ingredient category as Activen and supplies similar major brand customers.

Broad incumbents

  • Givaudan Active Beauty: Givaudan Active Beauty is a global leader in cosmetic ingredients and fragrance, offering biotech-derived actives, peptides, and natural extracts. It serves all major cosmetic brands with broader portfolio and deeper resources than Activen.
  • Evonik Care Solutions: Evonik's Care Solutions business produces specialty cosmetic ingredients including peptides, ceramides, and biotech actives, serving the same brand customers as Activen but as part of a much larger specialty chemicals portfolio.
  • DSM Personal Care & Aroma: DSM Personal Care develops and markets bioactive cosmetic ingredients, including peptides and vitamins, for major beauty brands globally. It is a broad incumbent offering biotech actives alongside vitamins and UV filters.

Emerging players

  • BIOEFFECT: BIOEFFECT uses biotechnology to produce growth factor-based skincare, including EGF. Its topical growth factor technology overlaps with Activen's XEP-716 TGF-β-targeting miniprotein, although BIOEFFECT markets finished skincare rather than B2B ingredients.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Activen Sa social profiles

Digital presence

Activen Sa financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Activen Sa leadership team

Management profile

Number of profiles

Profiles2 records

Activen Sa funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Activen Sa M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Activen Sa

What does Activen Sa do?

Activen develops and commercializes proprietary miniprotein™ active ingredients for the dermo-cosmetic industry. The company scouts genomic sequences of living organisms to identify small proteins that can penetrate the skin and modulate specific cellular receptors, then supplies these miniprotein actives to cosmetic brands and contract manufacturers for incorporation into anti-aging, skin regeneration, neuro-dermatology, and immuno-dermatology formulations. Its two commercial products are XEP®-018 (a muscle relaxant miniprotein for wrinkle reduction) and XEP®-716 (a growth factor miniprotein for skin rejuvenation).

Is Activen Sa a public or private company?

Activen Sa is a private company. It is classified as unknown and is currently operating.

When was Activen Sa founded?

Activen Sa was founded in 2011. It employs 1 to 10 people.

Where is Activen Sa based?

Activen Sa is headquartered in Lausanne, Switzerland, in the Europe region.

How does Activen Sa make money?

One revenue line is on record: active Ingredient Sales.

Who are Activen Sa's main competitors?

Direct peers on record are Lipotec (Lubrizol Life Science), CLR Berlin, Mibelle Biochemistry, Active Concepts, Sederma (Croda International) and Lucas Meyer Cosmetics (IFF). Broad incumbents are Givaudan Active Beauty, Evonik Care Solutions and DSM Personal Care & Aroma. BIOEFFECT is listed as an emerging player.

Does Activen Sa have an API?

No public API is recorded for Activen Sa.

What industry is Activen Sa in?

Activen Sa's product category is Dermo-cosmetic Active Ingredients. Its primary akta.pro industry code is CRABAAAF, Dermocosmetics & Medical-Grade Skincare, with a secondary code of CRABAAAB, Treatment Skincare (Serums, Actives, Acne & Anti-aging). Its NAICS code is 32561.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales